267 related articles for article (PubMed ID: 27526269)
1. Amelioration of bleomycin-induced lung fibrosis in rats by valproic acid and butyrate: Role of nuclear factor kappa-B, proinflammatory cytokines and oxidative stress.
Kabel AM; Omar MS; Elmaaboud MAA
Int Immunopharmacol; 2016 Oct; 39():335-342. PubMed ID: 27526269
[TBL] [Abstract][Full Text] [Related]
2. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.
Kalayarasan S; Sriram N; Sudhandiran G
Life Sci; 2008 Jun; 82(23-24):1142-53. PubMed ID: 18462759
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats.
El-Khouly D; El-Bakly WM; Awad AS; El-Mesallamy HO; El-Demerdash E
Toxicology; 2012 Dec; 302(2-3):106-13. PubMed ID: 22982510
[TBL] [Abstract][Full Text] [Related]
4. Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis.
Kabel AM; Estfanous RS; Alrobaian MM
Respir Physiol Neurobiol; 2020 Feb; 273():103316. PubMed ID: 31600583
[TBL] [Abstract][Full Text] [Related]
5. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
Toxicol Lett; 2013 May; 219(2):178-93. PubMed ID: 23523906
[TBL] [Abstract][Full Text] [Related]
6. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
[TBL] [Abstract][Full Text] [Related]
7. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
[TBL] [Abstract][Full Text] [Related]
9. Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.
Altintas N; Erboga M; Aktas C; Bilir B; Aydin M; Sengul A; Ates Z; Topcu B; Gurel A
Inflammation; 2016 Feb; 39(1):65-78. PubMed ID: 26253295
[TBL] [Abstract][Full Text] [Related]
10. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis.
Zhao L; Wang X; Chang Q; Xu J; Huang Y; Guo Q; Zhang S; Wang W; Chen X; Wang J
Eur J Pharmacol; 2010 Feb; 627(1-3):304-12. PubMed ID: 19909737
[TBL] [Abstract][Full Text] [Related]
11. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
Serrano-Mollar A; Closa D; Prats N; Blesa S; Martinez-Losa M; Cortijo J; Estrela JM; Morcillo EJ; Bulbena O
Br J Pharmacol; 2003 Mar; 138(6):1037-48. PubMed ID: 12684259
[TBL] [Abstract][Full Text] [Related]
12. Sinapic acid ameliorates bleomycin-induced lung fibrosis in rats.
Raish M; Ahmad A; Ahmad Ansari M; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Biomed Pharmacother; 2018 Dec; 108():224-231. PubMed ID: 30219680
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
[TBL] [Abstract][Full Text] [Related]
14. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
15. The Protective Effect of Naringin against Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats.
Turgut NH; Kara H; Elagoz S; Deveci K; Gungor H; Arslanbas E
Pulm Med; 2016; 2016():7601393. PubMed ID: 26977316
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
Verma R; Brahmankar M; Kushwah L; Suresh B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
[TBL] [Abstract][Full Text] [Related]
17. Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress.
Cui K; Kou JQ; Gu JH; Han R; Wang G; Zhen X; Qin ZH
BMC Complement Altern Med; 2014 Dec; 14():461. PubMed ID: 25465226
[TBL] [Abstract][Full Text] [Related]
18. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Gurujeyalakshmi G; Wang Y; Giri SN
J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9.
Abuelezz SA; Hendawy N; Osman WM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):897-909. PubMed ID: 27154762
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of rutin against bleomycin induced lung fibrosis: Involvement of TGF-β1/α-SMA/Col I and III pathway.
Bai L; Li A; Gong C; Ning X; Wang Z
Biofactors; 2020 Jul; 46(4):637-644. PubMed ID: 32233122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
